BERNINI, Franco
 Distribuzione geografica
Continente #
AS - Asia 14.584
NA - Nord America 14.356
EU - Europa 9.145
SA - Sud America 1.994
AF - Africa 717
Continente sconosciuto - Info sul continente non disponibili 16
OC - Oceania 12
Totale 40.824
Nazione #
US - Stati Uniti d'America 13.987
SG - Singapore 5.541
CN - Cina 3.997
VN - Vietnam 2.231
IE - Irlanda 1.638
BR - Brasile 1.558
FI - Finlandia 1.293
DE - Germania 1.197
HK - Hong Kong 1.196
SE - Svezia 1.162
IT - Italia 1.030
UA - Ucraina 914
ZA - Sudafrica 559
FR - Francia 555
TR - Turchia 550
NL - Olanda 453
GB - Regno Unito 263
CA - Canada 238
RU - Federazione Russa 206
IN - India 186
AR - Argentina 180
BD - Bangladesh 114
AT - Austria 106
IQ - Iraq 104
JP - Giappone 94
KR - Corea 78
ID - Indonesia 74
MX - Messico 73
EC - Ecuador 66
PL - Polonia 61
PH - Filippine 59
CO - Colombia 55
BE - Belgio 52
ES - Italia 49
CZ - Repubblica Ceca 48
VE - Venezuela 47
PK - Pakistan 44
TH - Thailandia 43
UZ - Uzbekistan 38
PY - Paraguay 31
TW - Taiwan 31
MA - Marocco 30
SA - Arabia Saudita 25
EG - Egitto 24
CL - Cile 20
KE - Kenya 20
JO - Giordania 19
AE - Emirati Arabi Uniti 18
CI - Costa d'Avorio 18
AL - Albania 17
IL - Israele 17
EU - Europa 15
KZ - Kazakistan 14
LT - Lituania 14
MY - Malesia 14
PE - Perù 14
DZ - Algeria 13
IR - Iran 13
TN - Tunisia 13
UY - Uruguay 13
OM - Oman 12
RO - Romania 12
ET - Etiopia 10
NP - Nepal 10
AU - Australia 9
TT - Trinidad e Tobago 9
AZ - Azerbaigian 8
BG - Bulgaria 8
DO - Repubblica Dominicana 8
HN - Honduras 8
HU - Ungheria 8
PA - Panama 8
BO - Bolivia 7
LB - Libano 7
BY - Bielorussia 6
KG - Kirghizistan 6
KW - Kuwait 6
QA - Qatar 6
RS - Serbia 6
SY - Repubblica araba siriana 6
BB - Barbados 5
CH - Svizzera 5
LU - Lussemburgo 5
MD - Moldavia 5
PS - Palestinian Territory 5
PT - Portogallo 5
SN - Senegal 5
CR - Costa Rica 4
GR - Grecia 4
JM - Giamaica 4
NG - Nigeria 4
NI - Nicaragua 4
AO - Angola 3
BH - Bahrain 3
CM - Camerun 3
CY - Cipro 3
DK - Danimarca 3
GE - Georgia 3
HR - Croazia 3
MK - Macedonia 3
Totale 40.771
Città #
Singapore 2.610
Dublin 1.638
Chandler 1.551
San Jose 1.484
Ashburn 1.299
Hong Kong 1.124
Jacksonville 1.115
Beijing 1.056
Santa Clara 880
Ho Chi Minh City 677
Dallas 609
Boardman 527
Johannesburg 525
Nanjing 508
Hanoi 505
Dearborn 498
Izmir 485
Princeton 388
Ann Arbor 376
Lauterbourg 361
New York 331
Parma 301
Wilmington 260
Los Angeles 251
Munich 240
San Mateo 234
Bremen 230
Hefei 180
Helsinki 179
Shanghai 164
Toronto 159
Shenyang 154
São Paulo 143
Nanchang 137
Hebei 134
Moscow 126
Kunming 118
Columbus 106
Council Bluffs 100
Jinan 98
Seattle 98
Haiphong 97
Buffalo 96
Des Moines 96
Tianjin 94
Vienna 91
Da Nang 85
Jiaxing 78
Woodbridge 74
Grafing 73
Changsha 70
Chicago 70
Guangzhou 63
Marseille 59
Norwalk 57
Seoul 55
Tokyo 53
Brussels 49
Milan 47
The Dalles 47
Warsaw 47
Zhengzhou 47
Hải Dương 46
Orem 46
Houston 44
Turku 44
Brooklyn 41
Frankfurt am Main 40
Biên Hòa 39
Pune 38
Rio de Janeiro 38
Rome 38
Baghdad 37
Belo Horizonte 37
Bologna 36
Chennai 33
Hangzhou 33
Tashkent 33
Jakarta 32
Montreal 32
Atlanta 29
Fremont 29
Brno 28
Brasília 27
Denver 27
San Francisco 27
Guayaquil 26
Ninh Bình 26
Nuremberg 26
Phoenix 26
Taiyuan 26
Curitiba 24
Can Tho 23
London 23
Stockholm 23
Düsseldorf 21
Manchester 21
Quito 21
Mexico City 20
Modena 20
Totale 24.587
Nome #
Activation profiles of monocyte-macrophages and HDL function in healthy women in relation to menstrual cycle and in polycystic ovary syndrome patients 326
A New ABCB1 Inhibitor Enhances the Anticancer Effect of Doxorubicin in Both In Vitro and In Vivo Models of NSCLC 273
Three-Dimensional (3D) Printed Silver Nanoparticles/Alginate/Nanocrystalline Cellulose Hydrogels: Study of the Antimicrobial and Cytotoxicity Efficacy 233
The adaptation of lipid profile of human fibroblasts to alginate 2D films and 3D printed scaffolds 229
PCSK9 ablation attenuates Aβ pathology, neuroinflammation and cognitive dysfunctions in 5XFAD mice 227
Cellular cholesterol efflux and cholesterol loading capacity of serum: effects of LDL-apheresis 215
Identification of 4-amino-2-Pyridones as new potent PCSK9 inhibitors: From phenotypic hit discovery to in vivo tolerability 214
ABCA1- and ABCG1-mediated cholesterol efflux capacity of cerebrospinal fluid is impaired in Alzheimer's disease 213
Anti-Inflammatory Properties of Statin-Loaded Biodegradable Lecithin/Chitosan Nanoparticles: A Step Toward Nose-to-Brain Treatment of Neurodegenerative Diseases 203
ABCA1-dependent serum cholesterol efflux capacity inversely correlates with pulse wave velocity in healthy subjects 185
ABCA1 MODULATES CELLULAR MIGRATION AND MEMBRANE RUFFLING INDUCED BY FREE CHOLESTEROL IN MACROPHAGES FOAM CELLS 180
Advance diagnostic support in lipidology project: role for phenotipic and functional evaluation of lipoproteins in dyslipidemias 179
Biocompatible 3d printed chitosan-based scaffolds containing α-tocopherol showing antioxidant and antimicrobial activity 177
A Short Term Administration of Cyclosporine A to Mice Inhibits the Reverse Cholesterol Transport from Macrophages 175
Antiatherogenic effects of ellagic acid and urolithins in vitro 172
Anti-atherogenic modification of serum lipoprotein function in patients with rheumatoid arthritis after tocilizumab treatment, a pilot study 172
Attivita' del Probucolo nell'inibire l'efflusso lipidico cellulare ABCA1-mediato 168
Highly defined 3D printed chitosan scaffolds featuring improved cell growth 167
CYCLOSPORINE A IMPAIRS THE REVERSE CHOLESTEROL TRANSPORT FROM MACROPHAGES IN VIVO BY REDUCING STEROL FECAL EXCRETION 163
CHOLESTEROL EFFLUX POTENTIAL OF SERA FROM PATIENTS BEFORE AND AFTER LDL-APHERESIS 162
Assessment of Cholesterol Efflux Potential of High-Density Lipoprotein after Treatment with Niacin Extended-Release or Fenofibrate 161
Effetto delle statine sull’efflusso ABCA1 in macrofagi e cellule epatiche 160
PROPROTEIN CONVERTASE SUBTILISIN/KEXIN TYPE 9 (PCSK9) GENETIC DELETION ATTENUATES AMYLOID-. PATHOLOGY, NEUROINFLAMMATION AND IMPROVES COGNITIVE FUNCTIONS IN AN ALZHEIMER'S DISEASE MOUSE MODEL 159
Alcohol pattern consumption differently affects the efficiency of macrophage reverse cholesterol transport in vivo 154
Increased PCSK9 Cerebrospinal Fluid Concentrations in Alzheimer's Disease 153
ABCA1 MODULATES CELLULAR MIGRATION AND MEMBRANE RUFFLING INDUCED BY FREE CHOLESTEROL IN MACROPHAGES FOAM CELLS 152
Study of 3D-printed chitosan scaffold features after different post-printing gelation processes 151
A unique protease-sensitive high density lipoprotein particle containing the apolipoprotein A-I(Milano) dimer effectively promotes ATP-binding Cassette A1-mediated cell cholesterol efflux 149
Ruolo dell’apolipoproteine E nell’efflusso cellulare di colesterolo 148
Abnormal splicing of ABCA1 pre-mRNA in Tangier disease due to a IVS2+5G>C mutation in ABCA1 gene 147
CHOLESTEROL EFFLUX POTENTIAL OF SERA FROM PATIENTS BEFORE AND AFTER LDL-APHERESIS 147
Influence of APOE4 genotype on PCSK9-lipids association in cerebrospinal fluid and serum of patients in the Alzheimer's disease continuum 146
New MDR1 inhibitors for overcoming multidrug resistance 146
Cyclosporine A modulates the macrophage reverse cholesterol transport in vivo 145
A NOVEL MUTATION IN CETP GENE AS A CAUSE OF CETP DEFICIENCY IN A CAUCASIAN KINDRED 145
Opposite effects of moderate and excess alcohol consumption on the atheroprotective process of the reverse cholesterol transport in vivo 144
A novel homozygous mutation in CETP gene as a cause of CETP deficiency in a caucasian kindred 144
Role of Apolipoprotein E in cellular cholesterol efflux 143
Effects of moderate and excess alcohol consumption on the reverse cholesterol transport in vivo 142
Cholesterol efflux capacity of sera from subjects with LCAT deficiency 141
5,6-diphenylpyridazine derivatives as acyl-Coacholesterol acyltransferase inhibitors 141
LA CICLOSPORINA A INIBISCE IL TRASPORTO INVERSO DEL COLESTEROLO NEI TOPI 141
CYCLOSPORINE A IMPAIRS THE REVERSE CHOLESTEROL TRANSPORT FROM MACROPHAGES IN VIVO BY REDUCING STEROL FECAL EXCRETION 141
LA CICLOSPORINA A RIDUCE IL TRASPORTO INVERSO DEL COLESTEROLO NEI TOPI ATTRAVERSO L’INIBIZIONE DELL’ESCREZIONE FECALE 141
Effetto della Ciclosporina A sul trasporto inverso del colesterolo in vivo 140
Cholesterol efflux and reverse cholesterol transport 140
Dietary Ellagitannin Metabolites Exert Antiatherosclerotic Effects in Vitro 139
Macrophage, But Not Systemic, Apolipoprotein E Is Necessary for Macrophage Reverse Cholesterol Transport In Vivo 139
Cellular cholesterol efflux pathways: Impact on Intracellular Lipid Trafficking and Methodological Considerations 138
A SHORT TERM ADMINISTRATION OF CYCLOSPORINE A IMPAIRS THE REVERSE CHOLESTEROL TRANSPORT FROM MACROPHAGES IN VIVO 138
Cholesterol efflux potential of sera from subjects with LCAT deficiency 137
CHOLESTEROL EFFLUX AND CHOLESTEROL LOADING CAPACITY OF SERA FROM PATIENTS BEFORE AND AFTER LDL-APHERESIS 137
Lercanidipine Reduces Free Cholesterol-Induced Cytotoxicity 137
Effect of vitamin D deficiency and replacement on serum HDL cholesterol efflux capacity in premenopausal women 137
Immunoglobulin G inhibit endothelial activation induced by atherogenic stimuli 136
CHARACTERIZATION OF THREE KINDRED WITH FAMILIAL COMBINED HYPOLIPIDEMIA DUE TO LOSS OF FUNCTION MUTATIONS OF ANGPTL3 136
SERUM CHOLESTEROL EFFLUX CAPACITY INVERSELY CORRELATES WITH ARTERIAL STIFFNESS IN HEALTHY SUBJECTS 136
The Gut Microbial Metabolite Trimethylamine-N-Oxide Is Present in Human Cerebrospinal Fluid 135
Dislipidemia diabetica e spessore medio-intimale, ruolo del trasporto inverso del colesterolo. 134
Hydrocortisone directly promotes cholesterol accumulation in macrophages. 134
CHOLESTEROL EFFLUX POTENTIAL OF SERA FROM DIABETIC PATIENTS: CLINICAL APPLICATIONS 134
CHOLESTEROL EFFLUX CAPACITY, HDL-C LEVELS AND CORONARY CALCIUM SCORE AMONG THE VERY ELDERLY SUBJECTS 133
EFFECT OF VITAMIN D REPLACEMENT ON SERUM LIPOPROTEIN FUNCTIONALITY IN HEALTHY PRE-MENOPAUSAL WOMEN 133
Functional pasta consumption in healthy volunteers modulates ABCG1-mediated cholesterol efflux capacity of HDL 133
Analysis of lipid efflux in fibroblasts from Niemann Pick Type C disease subjects 133
Effetto degli agonisti LXR sul trasporto inverso del colesterolo in vivo 133
Impaired ATP-binding cassette transporter A1-mediated sterol efflux from oxidized LDL-loaded macrophages 132
Natural anti-endothelial cell antibodies (AECA) 132
Effect of carvedilol on cholesterol esterification and nitric oxide synthesis in cultured macrophages 132
Increased PCSK9 cerebrospinal fluid concentrations in Alzheimer’s disease 131
Cyclosporine A Impairs the Macrophage Reverse Cholesterol Transport in Mice by Reducing Sterol Fecal Excretion 130
Cyclosporine a affects the reverse cholesterol transport from macrophages in vivo 130
Vitamin D replacement ameliorates serum lipoprotein functions, adipokine profile and subclinical atherosclerosis in pre-menopausal women 130
Probucol inhibits ABCA1-mediated cellular lipids efflux 129
Cholesterol efflux capacity and arterial stiffness: data from the brisighella heart study 129
New mechanisms for steroid pro-atherogenic action: up regulation of macrophage LDL receptors, down regulation of cholesterol efflux transporters and increase in intracelluar cholesterol stores. 128
Pitavastatin increases ABCA1-mediated lipid efflux from Fu5AH rat hepatoma cells 128
SERUM CHOLESTEROL EFFLUX CAPACITY INVERSELY CORRELATES WITH ARTERIAL STIFNESS IN HEALTY SUBJECTS 128
6-Keto-prostaglandin E1-sensitive adenylate cyclase and binding sites in membranes from platelets and cultured smooth muscle cells. 128
ANTIATHEROSCLEROTIC EFFECTS OF A NEW COMBINATION OF BERBERINE, MONACOLIN K AND MORUS ALBA: IMPROVEMENT OF HDL FUNCTION 128
Attivita’ del probucolo nell’inibire l’efflusso lipidico cellulare ABCA1 mediato 127
A novel homozigous mutation in CETP gene as a cause of CETP deficiency in a caucasian kindred 127
RUOLO DELLA SFINGOSINA 1-FOSFATO E DEL SUO RECETTORE S1P3 NEL TRASPORTO INVERSO DEL COLESTEROLO 126
An w-3 polyunsaturated fatty acid concentrate increases plasma HDL2 cholesterol and paraoxonase levels in patients with familial combined hyperlipidemia 125
Lacidipine modulates the secretion of matrix metalloproteinase-9 by human macrophages 125
Effect of an innovative pasta enriched with bioactive components and functional probiotics on HDL cholesterol efflux capacity 125
Cholesterol efflux capacity does not associate with coronary calcium, plaque vulnerability and telomere length in healthy octogenarians 125
The c-terminal domain of apolipoprotein A-I is involved in ABCA1-driven phopspholipid and cholesterol efflux 124
Pitavastatin Differently Modulates ATP Binding Cassette A1-Mediated Lipid Efflux in Macrophages and Hepatic Cells 124
A BENZODIAZEPINE ANALOGUE PROMOTES FAECAL STEROL EXCRETION IN APOA-I OVEREXPRESSING MICE 124
Depletion of Pre-{beta}-high Density Lipoprotein by Human Chymase Impairs ATP-binding Cassette Transporter A1- but Not Scavenger Receptor Class B Type I-mediated Lipid Efflux to High Density Lipoprotein 124
Natural anti-endothelial cell antibodies (AECA) 123
ATTIVITA’ IPOLIPIDEMIZZANTE DEL NUTRACEUTICO OLEACTIV® NEL MODELLO DEL CRICETO GOLDEN SYRIAN 123
27-Hydroxycholesterol modulation of low density lipoprotein metabolism in cultured human hepatic and extrahepatic cells 122
IN VIVO ACUTE SYSTEMIC INFLAMMATION, INDEPENDENTLY ON THE ETIOLOGY, AFFECTS HDL CHOLESTEROL EFFLUX CAPACITY 122
High density lipoprotein function is reduced in patients affected by genetic or idiopathic hypogonadism. 122
Anti-Atherosclerotic Effect of a Polyphenol-Rich Ingredient, Oleactiv®, in a Hypercholesterolemia-Induced Golden Syrian Hamster Model 121
Impaired ATP-binding cassette Transporter AI-mediated Sterols Efflux from Oxidized LDL Loaded Macrophages 120
Dual effect of statins on ABCA1-mediated lipid efflux from macrophages and hepatic cells 120
ROLE OF APOLIPOPROTEIN E IN CELLULAR CHOLESTEROL EFFLUX 120
Totale 14.850
Categoria #
all - tutte 143.949
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 143.949


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021420 0 0 0 0 0 0 0 0 0 59 305 56
2021/20221.594 46 17 13 58 36 95 185 211 92 151 81 609
2022/20236.014 702 447 306 439 738 672 54 332 2.042 42 177 63
2023/20242.168 126 244 66 73 151 603 122 157 49 82 157 338
2024/20257.487 137 454 533 428 762 711 229 336 966 732 582 1.617
2025/202614.763 1.262 1.575 1.738 1.283 2.356 806 2.129 573 2.098 943 0 0
Totale 41.390